The New England journal of medicine, vol. 372, no. 25, pp. 2387-2397 Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual) Universidade de São Paulo (USP) instacron:USP Cannon, C P, Blazing, M A, Giugliano, R P, McCagg, A, White, J A, Theroux, P, Darius, H, Lewis, B S, Ophuis, T O, Jukema, J W, De Ferrari, G M, Ruzyllo, W, De Lucca, P, Im, K, Bohula, E A, Reist, C, Wiviott, S D, Tershakovec, A M, Musliner, T A, Braunwald, E, Califf, R M, IMPROVE-IT Investigators & Clemmensen, P M 2015, ' Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes ', The New England Journal of Medicine, vol. 372, no. 25, pp. 2387-2397 . https://doi.org/10.1056/NEJMoa1410489 New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2015, 372 (25), pp.2387-97. ⟨10.1056/NEJMoa1410489⟩ New England Journal of Medicine, 372(25), 2387-2397 New England journal of medicine, 372(25), 2387-2397. Massachussetts Medical Society
Ok, C Y, Li, L, Xu-Monette, Z Y, Visco, C, Tzankov, A, Manyam, G C, Montes-Moreno, S, Dybkær, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Chen, J, Richards, K L, Hsi, E D, Choi, W W L, van Krieken, J H, Huh, J, Ai, W, Ponzoni, M, Ferreri, A J M, Farnen, J P, Møller, M B, Bueso-Ramos, C E, Miranda, R N, Winter, J N, Piris, M A, Medeiros, L J & Young, K H 2014, ' Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries ', Clinical Cancer Research, vol. 20, no. 9, pp. 2338-2349 . https://doi.org/10.1158/1078-0432.CCR-13-3157 Clinical Cancer Research, 20, 2338-2349 Clinical Cancer Research, 20, 9, pp. 2338-2349 Ok, C Y, Li, L, Xu-Monette, Z Y, Visco, C, Tzankov, A, Manyam, G C, Montes-Moreno, S, Dybkaer, K, Dybaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Chen, J, Richards, K L, Hsi, E D, Choi, W W L, van Krieken, J H, Huh, J, Ai, W, Ponzoni, M, Ferreri, A J M, Farnen, J P, Møller, M B, Bueso-Ramos, C E, Miranda, R N, Winter, J N, Piris, M A, Medeiros, L J & Young, K H 2014, ' Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries ', Clinical Cancer Research, vol. 20, no. 9, pp. 2338-2349 . https://doi.org/10.1158/1078-0432.CCR-13-3157
Clinical Cancer Research, 20, 5113-23 Ok, C Y, Chen, J, Xu-Monette, Z, Tzankov, A, Manyam, G, Li, L, Visco, C, Montes-Moreno, S, Dybkær, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, K L, Hsi, E D, Choi, W W, van Krieken, H, Huh, J, Zhao, X, Ponzoni, M, Ferreri, A J M, Bertoni, F, Farnen, J P, Moller, M B, Piris, M A, Winter, J N, Medeiros, L J & Young, K H 2014, ' Clinical Implications of Phosphorylated STAT3 Expression in de novo Diffuse Large B-cell Lymphoma ', Clinical Cancer Research, vol. 20, no. 19, pp. 5113-5123 . https://doi.org/10.1158/1078-0432.CCR-14-0683 Europe PubMed Central Ok, C Y, Chen, J, Xu-Monette, Z Y, Tzankov, A, Manyam, G C, Li, L, Visco, C, Montes-Moreno, S, Dybkær, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, K L, Hsi, E D, Choi, W W L, van Krieken, J H, Huh, J, Zhao, X, Ponzoni, M, Ferreri, A J M, Bertoni, F, Farnen, J P, Møller, M B, Piris, M A, Winter, J N, Medeiros, L J & Young, K H 2014, ' Clinical Implications of Phosphorylated STAT3 Expression in De Novo Diffuse Large B-cell Lymphoma ', Clinical Cancer Research, vol. 20, no. 19, pp. 5113-5123 . https://doi.org/10.1158/1078-0432.CCR-14-0683 Clinical Cancer Research, 20, 19, pp. 5113-23
Visco, C, Tzankov, A, Xu-Monette, Z Y, Miranda, R N, Tai, Y C, Li, Y, Liu, W M, d'Amore, E S G, Li, Y, Montes-Moreno, S, Dybkær, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Wang, H Y, Dunphy, C H, His, E D, Zhao, X F, Choi, W W L, Zhao, X, Han van Krieken, J, Huang, Q, Ai, W, O'Neill, S, Ponzoni, M, Ferreri, A J M, Kahl, B S, Winter, J N, Go, R S, Dirnhofer, S, Piris, M A, Møller, M B, Wu, L, Medeiros, L J & Young, K H 2013, ' Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status : A report from an international DLBCL rituximab-CHOP consortium program study ', Haematologica, vol. 98, no. 2, pp. 255-263 . https://doi.org/10.3324/haematol.2012.066209 Visco, C, Tzankov, A, Xu-Monette, Z Y, Miranda, R N, Tai, Y C, Li, Y, Liu, W-M, d'Amore, E S G, Li, Y, Montes-Moreno, S, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Wang, H-Y, Dunphy, C H, O' Neill, S, Hsi, E D, Zhao, X F, Choi, W W L, Zhao, X, van Krieken, J H, Huang, Q, Ai, W, Ponzoni, M A, Ferreri, A J M, Kahl, B S, Winter, J N, Go, R S, Dirnhofer, S, Piris, M A, Møller, M B, Wu, L, Medeiros, L J & Young, K H 2012, ' Patients with diffuse large B cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status : a report from an International DLBCL rituximab-CHOP Consortium Program Study ', Haematologica . https://doi.org/10.3324/haematol.2012.066209 Haematologica, 98, 255-63 Haematologica, 98, 2, pp. 255-63